What are the optimal walking tests to assess disability progression? by Pierard, Sébastien & Van Droogenbroeck, Marc
What are the optimal walking tests
to assess disability progression?
Sébastien PiérardSebastien.Pierard@ulg.ac.be Marc Van DroogenbroeckM.VanDroogenbroeck@ulg.ac.be
INTELSIG, Montefiore Institute, University of Liège, Belgium
Introduction and objective
Therapy success is assumed when there is no evidence of disease activity, and especially no
evidence of disability progression. Gait analysis plays a major role as gait impairment is
considered by patients as the most disabling symptom [1]. Monitoring this phenomenon is
thus important in the clinical setting. But how should we do this?
By selecting an appropriate technology, it is possible to measure many spatiotemporal gait
parameters, describing both the swing and stance phases, even during long tests (e.g. 6min,
500m), without equipping patients with markers or sensors. Comfortable (at self selected
speed), as fast as possible, and heel-to-toe (tandem) walking are typical tests. In this work,
we determine if there is an advantage to perform various walking tests (in a reasonable
amount of acquisition time), and which test or combination of tests is the most informative
about the patient state. We focus on the ability to take objective decisions based on the
measured gait parameters.
Method
• Many healthy volunteers (469 visits) and MS patients (86 visits) performed 12 tests:
1 comfortable on a straight path of 25 ft (7.62 m)
2 comfortable on a straight path of 25 ft (second try)
3 as fast as possible on a straight path of 25 ft
4 as fast as possible on a straight path of 25 ft (second try)
5 tandem on a straight path of 25 ft
6 tandem on a straight path of 25 ft (second try)
7 comfortable on a ∞-shaped path of 20 m
8 as fast as possible on a ∞-shaped path of 20 m
9 tandem on a ∞-shaped path of 20 m
10 comfortable on a ∞-shaped path of 100 m (5 laps of 20 m)
11 as fast as possible on a ∞-shaped path of 100 m (5 laps of 20 m)
12 as fast as possible on a ∞-shaped path of 500 m (25 laps of 20 m)
• All tests were recorded and analyzed with a gait measuring system GAIMS [2, 3, 4]. 26
gait parameters were computed for each test, and normalized with respect to those of
healthy people with the same morphological characteristics (weight, height, age,
gender, shoesize) as in [5].
Figure 1: The gait measuring system GAIMS [2, 3, 4] measures feet trajectories with range laser scanners (the
patient does not need to carry any marker or sensor) and derives many gait characteristics.
• To assess the ability to detect disability progression based on these clinical outcome
measures, we evaluate the possibility of differentiating the people below a given EDSS
threshold (0.75) from those above it based only on the measured gait parameters. We
measure (by leave-one-person-out) the performance of the 12 classifiers learned
automatically with the machine learning technique named ExtRaTrees (a forest of
decision trees) [6]. They predict the probability of MS given the gait characteristics,
























true healthy person visit rate, TNR (%)
ROC curves for 494 visits (434 -, 60 +)
Random classifiers25ft, comfo.: MBA=76.9%, AUC=0.82625ft, comfo.: MBA=71.0%, AUC=0.76525ft, fast: MBA=85.3%, AUC=0.92225ft, fast: MBA=82.5%, AUC=0.89725ft, tandem: MBA=81.2%, AUC=0.86025ft, tandem: MBA=79.2%, AUC=0.87620m, comfo.: MBA=84.7%, AUC=0.91320m, fast: MBA=86.3%, AUC=0.92720m, tandem: MBA=85.0%, AUC=0.912100m, comfo.: MBA=81.8%, AUC=0.874100m, fast: MBA=88.8%, AUC=0.925500m, fast: MBA=87.9%, AUC=0.959Unachievable performance: MBA=88.8%, AUC=0.966
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12
T1 1.00 0.53 0.46 0.44 0.38 0.34 0.49 0.47 0.34 0.48 0.47 0.46
T2 0.53 1.00 0.40 0.44 0.44 0.39 0.48 0.42 0.35 0.51 0.40 0.37
T3 0.46 0.40 1.00 0.66 0.37 0.34 0.54 0.63 0.37 0.51 0.59 0.61
T4 0.44 0.44 0.66 1.00 0.34 0.33 0.49 0.64 0.37 0.49 0.58 0.60
T5 0.38 0.44 0.37 0.34 1.00 0.65 0.40 0.43 0.64 0.43 0.46 0.44
T6 0.34 0.39 0.34 0.33 0.65 1.00 0.32 0.42 0.60 0.37 0.41 0.40
T7 0.49 0.48 0.54 0.49 0.40 0.32 1.00 0.52 0.38 0.61 0.47 0.49
T8 0.47 0.42 0.63 0.64 0.43 0.42 0.52 1.00 0.48 0.53 0.73 0.67
T9 0.34 0.35 0.37 0.37 0.64 0.60 0.38 0.48 1.00 0.44 0.48 0.46
T10 0.48 0.51 0.51 0.49 0.43 0.37 0.61 0.53 0.44 1.00 0.57 0.58
T11 0.47 0.40 0.59 0.58 0.46 0.41 0.47 0.73 0.48 0.57 1.00 0.73
T12 0.46 0.37 0.61 0.60 0.44 0.40 0.49 0.67 0.46 0.58 0.73 1.00
Figure 2: The performance of the 12 classifiers (learned automatically from the corresponding gait tests) gives
an indication about the quantity of useful information grabbed during the corresponding tests. Left: the ROC
curves. Right: Pairwise Pearson correlations between the values predicted by different classifiers.
• As the classifiers are poorly correlated, we expect some benefits by combining them.
Thus, we study the performance that can be achieved by combining the decisions of
these 12 classifiers, or any subset of them. We assume that the optimal walking tests
to assess disability progression are those leading to the best performance. Four
combination strategies are analyzed: the probabilistic product [7], the median (related
to a majority vote), the mean, and a weighted average (we determined the weights
using a linear support vector machine with a soft margin and controlling its
hyper-parameter C to avoid over-fitting and negative weights).
Results
The ability to detect the disability progression is quantified by the area under the ROC curve
(AUC) and the maximum achievable balanced accuracy (MBA) of the combination. We show
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Figure 3: The ability to detect the disability progression depends on the set of gait analysis tests considered.
This figure has been obtained with the combining rule “mean”; the behavior is similar for the other
combination rules tested. Left: maximum balanced accuracy. Right: area under the ROC curve.
In order to choose the best set of clinical tests, we ranked them according to the two metrics,
and for all four combination rules. Our advice is to select the set of tests that has the best
(smallest) average rank. For the purpose of ranking, a small penalty of 1 % per 500 m has
been considered for both the MBA and the AUC in order to prefer the shortest sets.
selected classifiers (walking tests) total ranks (/1727)
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 walked svm, w.r.t. mean, w.r.t. median, w.r.t. product, w.r.t. mean
distance [m] MBA AUC MBA AUC MBA AUC MBA AUC rank
V V V V 55.24 59 3 10 1 36 1 13 3 15.8
V V V V V 75.24 53 13 3 3 12 41 3 2 16.2
V V V V V 62.86 62 4 29 7 7 22 31 10 21.5
V V V V V V 70.48 9 1 67 19 11 13 65 1 23.2
V V V V V 50.48 75 36 21 9 17 6 36 14 26.8
V V V V 67.62 71 26 56 12 27 18 2 4 27.0
V V V V V V V 90.48 54 9 48 18 40 45 20 5 29.9
V V V V V V 82.86 65 21 40 8 18 8 75 18 31.6
V V V V V 555.24 17 78 16 37 34 53 6 15 32.0
V V V V V V V V 578.10 23 69 35 57 24 47 19 27 37.6
Table 1: The top-10 sets of tests for clinical gait analysis. We recommend to rely on the tests 3, 4, 7, and 9.
Considering other, less, or more tests would decrease the usefulness of clinical gait analysis.
An indicator about the patient’s state can be obtained as follows. For each test in the
selected set (3, 4, 7, and 9), the probability of MS is predicted based on the measures.
These predictions are then combined by averaging. This gives us a correct decision rate
(balanced accuracy) of 93.9 % when differentiating between EDSS = 0 (assumption for
healthy people) and EDSS ∈ [1.5, 5.5]. But most importantly, it is possible to recognize
most healthy people and most MS patients with 100 % certainty (the ROC curve follows the
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The classifier performance is
used to study the sensitivity
to the disease progression
around this threshold
Figure 4: The usefulness of a gait-based predicted score (probability of MS) obtained by analyzing the
measures taken during 4 tests, for a total walking distance of 55.24 m only. Left: the ROC curve
corresponding to the ability to detect a modification of the EDSS around 0.75. Right: the relationship with
the EDSS shows that the predicted probability of MS quickly increases in the first steps of the disease.
Conclusions
• With an appropriate measuring system, the clinical gait analysis can help to detect
disability progression.
• Despite they are considered as standardized, the shortest (25 ft) walking tests are the
worst when considered alone, while the longest (100 m, 500 m) ones are the best.
• Combining different walking tests improves the ability to take decisions, but the tests
should be carefully selected. Considering more tests than necessary can deteriorate the
usefulness of clinical gait analysis.
• We have studied 1727 sets of tests. Our advice is to consider 4 tests for a total walking
distance of 55.24 m only: two 25 ft walked as fast as possible, one 20 m with a
comfortable pace on a ∞-shaped path, and one 20 m in tandem gait.
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